In hemodialysis patients, several studies have shown that elevated serum C-reactive protein (CRP) levels have associationed with high cardiovascular morbidity and mortality.
In March 2002, Ushibuka City Hospital was reconstructed and the dialysis solution supply system was improved. The mean level of dialysate endotoxin (ET) at the end of the dialysate supplying line decreased from 76.9 to less than 1.0EU/L (ultrapure dialysate). We evaluated the relationship between dialysate ET levels and chronic inflammation determined by CRP.
The study subjects consisted of 23 patients receiving chronic hemodialysis at Ushibuka City Hospital. We prospectively measured high sensitivity CRP (h-CRP), hemoglobin, β
2-MG and serum albumin before the use of ultrapure dialysate and 1 year after its use was started.
The data showed a significant decrease in the median value of h-CRP from 0.162 to 0.073mg/dL (p<0.05). The value of β
2-MG was decreased from 33.2±2.1 to 28.4±1.4mg/L (p<0.001), hemoglobin level was increased from 10.01±0.23 to 10.95±0.23g/dL (p<0.01) despite the increasing erythropoietin level, and the albumin level was increased from 3.67±0.08 to 3.89±0.07g/dL (p<0.01).
These results indicate that even a dialysate containing about 70EU/L of ET may induce chronic inflammation, anemia, increasing levels of β
2-MG and hypoalbuminemia. Based on these results, the target ET level at the end of dialysate supply line should be 1.0EU/L or less.
View full abstract